Literature DB >> 7651642

Improving compliance among women with abnormal Papanicolaou smears.

E D Paskett1, K C Phillips, M E Miller.   

Abstract

OBJECTIVE: To determine whether a clinic-based intervention, consisting of motivational brochures and a tracking system, increases adherence to recommendations for treatment in women with abnormal Papanicolaou smears.
METHODS: Three pairs of clinics--two family planning clinics, two family practice clinics, and two dysplasia clinics--were randomized within pairs either to provide the intervention or to maintain usual contact procedures with women having abnormal Papanicolaou smears. Baseline adherence rates were assessed through chart review during 3 randomly selected months of the previous year. Intervention clinics received the tracking system and motivational brochures, which were sent to women on notification of their cervical abnormalities. Comparison clinics also used the tracking system but did not include the brochures when notifying women of their abnormalities. Adherence rates were assessed prospectively for approximately 100 consecutive nonpregnant women with abnormal Papanicolaou smears (inflammatory benign atypia, or cervical intraepithelial neoplasia I, II, or III) at each clinic.
RESULTS: Within clinics, baseline adherence rates ranged from 34-69% for atypia and 33-88% for dysplasia. For dysplasia patients, the overall analysis indicated a significant increase in adherence for the intervention clinics (P = .03); however, for atypia patients, the observed difference was not statistically significant (P = .23). Extensive analyses of the data from family planning clinics indicated that women receiving the intervention were more likely to obtain follow-up treatment (odds ratio [OR] 2.6, 95% confidence interval 1.15-5.85). There was a suggestion that the intervention could have a greater effect among African-American women (OR 15.7) compared with white women (OR 1.8) (P = .09). White women, those with dysplasia, nonsmokers, and nulliparas were most likely to adhere to treatment recommendations.
CONCLUSION: A motivational brochure can enhance adherence to treatment recommendations among women with abnormal Papanicolaou smears. Future studies should focus on techniques for enhancing adherence among more resistant participants.

Entities:  

Mesh:

Year:  1995        PMID: 7651642     DOI: 10.1016/0029-7844(95)00176-R

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

1.  Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-12-05       Impact factor: 2.681

Review 2.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

3.  Using the word 'cancer' in communication about an abnormal Pap test: finding common ground with patient-provider communication.

Authors:  Melissa A Simon; Ludmila Cofta-Woerpel; Veenu Randhawa; Priya John; Gregory Makoul; Bonnie Spring
Journal:  Patient Educ Couns       Date:  2010-01-08

4.  Tailored telephone counseling to improve adherence to follow-up regimens after an abnormal pap smear among minority, underserved women.

Authors:  Suzanne M Miller; Siu-kuen Azor Hui; Kuang-Yi Wen; John Scarpato; Fang Zhu; Joanne Buzaglo; Enrique E Hernandez
Journal:  Patient Educ Couns       Date:  2013-08-19

Review 5.  Is default from colposcopy a problem, and if so what can we do? A systematic review of the literature.

Authors:  H Lester; S Wilson
Journal:  Br J Gen Pract       Date:  1999-03       Impact factor: 5.386

6.  Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population.

Authors:  Karin Nelson; Ann M Geiger; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

7.  Patient barriers to follow-up care for breast and cervical cancer abnormalities.

Authors:  Silvia Tejeda; Julie S Darnell; Young I Cho; Melinda R Stolley; Talar W Markossian; Elizabeth A Calhoun
Journal:  J Womens Health (Larchmt)       Date:  2013-05-14       Impact factor: 2.681

Review 8.  Interventions targeted at women to encourage the uptake of cervical screening.

Authors:  Thomas Everett; Andrew Bryant; Michelle F Griffin; Pierre Pl Martin-Hirsch; Carol A Forbes; Ruth G Jepson
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

Review 9.  Interventions targeted at women to encourage the uptake of cervical screening.

Authors:  Helen Staley; Aslam Shiraz; Norman Shreeve; Andrew Bryant; Pierre Pl Martin-Hirsch; Ketankumar Gajjar
Journal:  Cochrane Database Syst Rev       Date:  2021-09-06

10.  Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005-2014.

Authors:  Sally Peprah; Jenell S Coleman; Anne F Rositch; Christopher J Vanden Bussche; Richard Moore; Gypsyamber D'Souza
Journal:  Papillomavirus Res       Date:  2018-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.